应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
PSC Principal U.S. Small-Cap Multi-Factor ETF
盘前交易 07-09 07:02:10 EDT
53.85
+0.09
+0.17%
最高
54.15
最低
53.77
成交量
13.57万
今开
54.15
昨收
53.76
日振幅
0.70%
总市值
7.66亿
流通市值
7.66亿
总股本
1,422万
成交额
731.16万
换手率
0.95%
流通股本
1,422万
市净率
--
ROE
--
每股收益
0.90
52周最高
57.24
52周最低
42.36
市盈率
59.83
股息
0.40
股息收益率
0.01
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
高价收技术，持续巨亏！探秘天价股权激励背后的故事
星空财研 · 2024-11-07
高价收技术，持续巨亏！探秘天价股权激励背后的故事
前宣武医院主任携泽辉生物赴港IPO，中国科学院成“关键先生”
蓝鲸财经 · 2024-10-30
前宣武医院主任携泽辉生物赴港IPO，中国科学院成“关键先生”
泽辉生物冲刺港交所，干细胞药物研发到哪一步了？
中新经纬 · 2024-10-15
泽辉生物冲刺港交所，干细胞药物研发到哪一步了？
一图解码：泽辉生物冲击港股IPO 致力于PSC来源疗法研发 尚未商业化
财华社 · 2024-10-03
一图解码：泽辉生物冲击港股IPO 致力于PSC来源疗法研发 尚未商业化
加载更多
公司概况
公司名称：
Principal U.S. Small-Cap Multi-Factor ETF
所属市场：
NASDAQ
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"PSC","market":"US","secType":"STK","nameCN":"Principal U.S. Small-Cap Multi-Factor ETF","latestPrice":53.85,"timestamp":1752004800000,"preClose":53.76,"halted":0,"volume":135650,"delay":0,"floatShares":14220001,"shares":14220001,"eps":0.9,"marketStatus":"盘前交易","change":0.09,"latestTime":"07-09 07:02:08 EDT","open":54.15,"high":54.15,"low":53.7715,"amount":7311632.668,"amplitude":0.007041,"askPrice":56.27,"askSize":89,"bidPrice":51.43,"bidSize":89,"shortable":3,"etf":1,"ttmEps":0.9,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752067800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":53.85,"sharesOutstanding":14220001,"nav":54.387567,"aum":763563295.3,"dividendRate":0.007428,"bidAskSpread":0.00169,"postHourTrading":{"tag":"盘后","latestPrice":53.85,"preClose":53.85,"latestTime":"16:04 EDT","volume":4,"amount":215.4,"timestamp":1752005051693},"volumeRatio":2.949695351419555},"requestUrl":"/m/hq/s/PSC","defaultTab":"news","newsList":[{"id":"2482460615","title":"高价收技术，持续巨亏！探秘天价股权激励背后的故事","url":"https://stock-news.laohu8.com/highlight/detail?id=2482460615","media":"星空财研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482460615?lang=zh_cn&edition=full","pubTime":"2024-11-07 17:25","pubTimestamp":1730971523,"startTime":"0","endTime":"0","summary":"大家都知道，国内在生物医药领域和头部国家们还有较大的差距，不过近些年来在不少细分领域，国内企业奋起直追，在极个别领域中取得了先发优势。来自北京的泽辉生物科技有限公司（简称：泽辉生物）就是一家拥有一定....","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OnBtud3hHHSUJfUN3MzlzrCLwW7FdFS0pgqjVhJ3JyiQEAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OnBtud3hHHSUJfUN3MzlzrCLwW7FdFS0pgqjVhJ3JyiQEAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241107A078B300","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241107A078B300","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["PSC","BK4139","ARDS","02197","BK1161","02257"],"gpt_icon":0},{"id":"2479833780","title":"前宣武医院主任携泽辉生物赴港IPO，中国科学院成“关键先生”","url":"https://stock-news.laohu8.com/highlight/detail?id=2479833780","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479833780?lang=zh_cn&edition=full","pubTime":"2024-10-30 23:11","pubTimestamp":1730301095,"startTime":"0","endTime":"0","summary":"（图片来源：视觉中国）蓝鲸新闻10月30日讯（记者 邵雨婷）今年，干细胞市场风起云涌。日前，中国专家牵头制定了全球首个干细胞数据国际标准，中国首个干细胞创新药也申报上市，干细胞创新药有望在国内掀起商业化浪潮。2024年9月30日，专注研发干细胞创新药的泽辉生物科技有限公司（以下简称“泽辉生物”）向港交所递交招股...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/Osr--0F7KMiVZqv7CmBLJoBcYpoOlRHAkY9X3uyNNV89sAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Osr--0F7KMiVZqv7CmBLJoBcYpoOlRHAkY9X3uyNNV89sAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241030A0AGTX00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241030A0AGTX00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["PSC"],"gpt_icon":0},{"id":"2475545893","title":"泽辉生物冲刺港交所，干细胞药物研发到哪一步了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2475545893","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475545893?lang=zh_cn&edition=full","pubTime":"2024-10-15 15:29","pubTimestamp":1728977365,"startTime":"0","endTime":"0","summary":"近日，泽辉生物向港交所递表，将申请主板挂牌上市。招股书显示，泽辉生物成立于2017年，专注于干细胞药物研发与生产。在细胞治疗备受资本与市场关注的当下，泽辉生物能从中分一杯羹吗？切中干细胞创新药风口泽辉生物招股书称，根据弗若斯特沙利文的资料，该公司是中国首批获得PSC（多能干细胞）来源细胞疗法新药临床试验申...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/O2_tz3t3jTP51uQLm9rAhUY_R9JVyq1jT3VLKL0Sj1sjoAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/O2_tz3t3jTP51uQLm9rAhUY_R9JVyq1jT3VLKL0Sj1sjoAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241015A05LDR00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241015A05LDR00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1574","BK1161","PSC","06978"],"gpt_icon":0},{"id":"2472631825","title":"一图解码：泽辉生物冲击港股IPO 致力于PSC来源疗法研发 尚未商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2472631825","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472631825?lang=zh_cn&edition=full","pubTime":"2024-10-03 10:23","pubTimestamp":1727922203,"startTime":"0","endTime":"0","summary":"9月30日，泽辉生物向港交所递交了招股书，计划在主板挂牌上市；由中金公司担任独家保荐人。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202410_1/0f81ceca-bcac-4e55-a9d7-3e7f516592df.jpg","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202410_1/0f81ceca-bcac-4e55-a9d7-3e7f516592df.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/66fe001bbde0b3449f7a10cc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["PSC","09633","HSTECH","YANG"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.principalfunds.com/fund/PSC","stockEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":0.0238},{"period":"3month","weight":0.1576},{"period":"6month","weight":0.0422},{"period":"1year","weight":0.1282},{"period":"ytd","weight":0.0503}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.021368},{"month":2,"riseRate":0.555556,"avgChangeRate":0.007268},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.032339},{"month":4,"riseRate":0.555556,"avgChangeRate":0.010744},{"month":5,"riseRate":0.666667,"avgChangeRate":0.015187},{"month":6,"riseRate":0.777778,"avgChangeRate":0.018849},{"month":7,"riseRate":0.888889,"avgChangeRate":0.029605},{"month":8,"riseRate":0.375,"avgChangeRate":-0.006333},{"month":9,"riseRate":0.375,"avgChangeRate":-0.013768},{"month":10,"riseRate":0.555556,"avgChangeRate":-0.005562},{"month":11,"riseRate":0.777778,"avgChangeRate":0.059547},{"month":12,"riseRate":0.666667,"avgChangeRate":0.001231}],"exchange":"NASDAQ","name":"Principal U.S. Small-Cap Multi-Factor ETF","nameEN":"Principal U.S. Small-Cap Multi-Factor ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Principal U.S. Small-Cap Multi-Factor ETF(PSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Principal U.S. Small-Cap Multi-Factor ETF(PSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Principal U.S. Small-Cap Multi-Factor ETF,PSC,Principal U.S. Small-Cap Multi-Factor ETF股票,Principal U.S. Small-Cap Multi-Factor ETF股票老虎,Principal U.S. Small-Cap Multi-Factor ETF股票老虎国际,Principal U.S. Small-Cap Multi-Factor ETF行情,Principal U.S. Small-Cap Multi-Factor ETF股票行情,Principal U.S. Small-Cap Multi-Factor ETF股价,Principal U.S. Small-Cap Multi-Factor ETF股市,Principal U.S. Small-Cap Multi-Factor ETF股票价格,Principal U.S. Small-Cap Multi-Factor ETF股票交易,Principal U.S. Small-Cap Multi-Factor ETF股票购买,Principal U.S. Small-Cap Multi-Factor ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Principal U.S. Small-Cap Multi-Factor ETF(PSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Principal U.S. Small-Cap Multi-Factor ETF(PSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}